Solid Biosciences
SLDB
58 hedge funds and large institutions have $119M invested in Solid Biosciences in 2018 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3.11% more ownership
Funds ownership: 0% → 3.11% (+3.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$75.2M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$60.5M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$44.8M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$16.9M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$15.4M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $12.7K | +$38.2K | +113 | New |
|
52
Legal & General Group
London,
United Kingdom
| $12K | +$36.1K | +107 | New |
|
53
First Manhattan
New York
| $7K | +$22.6K | +67 | New |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | +$17.2K | +51 | New |
|
55
CIBC Private Wealth Group
Atlanta,
Georgia
| $6K | +$18.6K | +55 | New |
|
56
Bank of America
Charlotte,
North Carolina
| $6K | +$19.2K | +57 | New |
|
|
ML
57
McAdam LLC
Philadelphia,
Pennsylvania
| – | +$1.01K | +3 | New |
|
58
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$1.35K | +4 | New |
|
SLDB Hedge Fund Activity: Q1 2018 in Review
58 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2018, worth a combined $119M.
Buyers outnumbered sellers: 58 funds opened new SLDB positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $75.2M.
- 58 institutional investors held Solid Biosciences (SLDB) as of Q1 2018, up from 0 in Q4 2017.
- Funds reported $119M of Solid Biosciences stock for Q1 2018.
- 58 funds opened new Solid Biosciences positions in Q1 2018 and 0 closed out, a net change of +58 holders.
- The largest Solid Biosciences buyer in Q1 2018 was JP Morgan Chase, an estimated $75.2M added.
Based on aggregated 13F filings for Q1 2018.